Curcumin exerts broad-spectrum antitumor effects by precisely intervening in the glucose metabolism of tumor cells, notably by suppressing key glycolytic enzymes such as HK2, PKM2, and LDHA, as well as GLUT1 and MCTs, thereby effectively reversing the Warburg effect. This evidence concerns the gene SLC2A1 and neoplasm.